NICE yes for Xarelto to treat blood clots
03:30 EDT 25 Jul 2012 | InPharm
NICE is recommending Bayer’s Xarelto (rivaroxaban) for the treatment and prevention of deep vein thrombosis (DVT). The watchdog said in its final guidance that Xarelto is now an option for treating deep vein thrombosis and preventing recurrent deep..
Original Article: NICE yes for Xarelto to treat blood clots
More From BioPortfolio on "NICE yes for Xarelto to treat blood clots"
Biotech & Healthcare Channels
World News
Life Science Events
Corporate Database
Market Reports
Categories
Search BioPortfolio:
